VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

812 hedge funds and large institutions have $53.4B invested in Vertex Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 165 funds opening new positions, 277 increasing their positions, 265 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
812
Holders Change
+106
Holders Change %
+15.01%
% of All Funds
16.03%
Holding in Top 10
18
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.36%
New
165
Increased
277
Reduced
265
Closed
41
Calls
$369M
Puts
$388M
Net Calls
-$19.3M
Net Calls Change
+$34.7M

Top Buyers

1
Capital International Investors
Capital International Investors
California
+$710M
2
Renaissance Technologies
Renaissance Technologies
New York
+$280M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$127M
4
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$104M
5
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$97.6M

Top Sellers

1
Invesco
Invesco
Georgia
-$562M
2
Jennison Associates
Jennison Associates
New York
-$527M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$386M
4
ClearBridge Investments
ClearBridge Investments
New York
-$196M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$191M
Name Holding Trade Value Shares
Change 		Shares
Change %
LGWM
851
Litman Gregory Wealth Management
California
– -$1K -7 Closed
31 32 33 34
35